CTRI/2020/10/028324已完成未知
Prospective , multi center ,open label, pilot study on evaluation of use of , â??AyurCoro-3â?? for prophylaxis purpose in frontline health care workers involved in treating COVID-19 patients. - AyurCoro3 Prophylaxis
Bhaktivedanta Hospital and Research Institute0 个研究点目标入组 120 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy frontline health care workers ,18 years and above , all genders who are involved in treating COVID-19 patients
排除标准
- •1.COVID-19 serology tests positive tests (Institute conducted it recently on all employees) .
- •2. Experiencing covid 19 symptoms at the time of admission .
- •3. Already taking some kind of prophylaxis for covid-19 at the time of study enrollment or had taken it within one month of study enrollment .
- •4. Working less than 3 days a week in the Hospital.
研究者
相似试验
进行中（未招募）
不适用
Prospective, open-label, multicenter, international study of mifepristone for symptomatic treatment of Cushing's syndrome caused by ectopic Adrenal Corticotrophin Hormone (ACTH) secretion. - HRA052015 in EASEUCTR2006-004679-36-FRaboratoire HRA Pharma22
进行中（未招募）
不适用
Prospective, open-label, multicenter, international study of mifepristone for symptomatic treatment of Cushing s syndrome caused by ectopic Adrenal Corticotrophin Hormone ACTH secretion - HRA052015 in EASEUCTR2006-004679-36-ITABORATOIRE HRA PHARMA22
进行中（未招募）
不适用
Prospective, open-label, multicenter, international study of mifepristone for symptomatic treatment of Cushing's syndrome caused by ectopic Adrenal Corticotrophin Hormone (ACTH) secretion. - HRA052015 in EASEUCTR2006-004679-36-NLaboratoire HRA Pharma22
进行中（未招募）
不适用
Prospective, open-label, multicenter, international study of mifepristone for symptomatic treatment of Cushing's syndrome caused by ectopic Adrenal Corticotrophin Hormone (ACTH) secretion. - HRA052015 in EASTreatment of Cushing's syndrome caused by ectopic Adrenal Corticotrophin Hormone (ACTH) secretion.MedDRA version: 14.0Level: PTClassification code 10011652Term: Cushing's syndromeSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.0Level: PTClassification code 10014146Term: Ectopic ACTH syndromeSystem Organ Class: 10014698 - Endocrine disordersEUCTR2006-004679-36-DEaboratoire HRA Pharma35
招募中
4 期
A Post Marketing Surveillance study of BCG vaccine in Indian populatioCTRI/2009/091/000669Green Signal BioPharma Pvt. Ltd., Chennai, India1,000